Physician profile
David A Gordon
NPI 1407819642
$4,890.31
in general payments reported to CMS, 2019-2025
28 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $615 · 2021: $736 · 2022: $1,063 · 2023: $1,137 · 2024: $473 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $963.05 | 2019-2025 | Speedicath |
| Medtronic, INC. | $797.85 | 2021-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $531.26 | 2023-2025 | Gemtesa |
| Allergan, INC. | $436.27 | 2019-2021 | |
| Caldera Medical, INC | $332.11 | 2021-2022 | |
| Urovant Sciences INC | $317.99 | 2021-2022 | |
| Astellas Pharma US INC | $204.54 | 2019-2023 | Myrbetriq |
| Ambu INC. | $165.70 | 2022-2023 | |
| Nevro Corp. | $161.15 | 2020-2021 | |
| Acell, INC. | $127.26 | 2019-2020 | |
| Boston Scientific Corporation | $121.49 | 2019-2023 | Wavewriter Alpha Prime 16, Solyx Sis System |
| Abbvie INC. | $120.89 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $106.40 | 2023 | |
| Janssen Biotech, INC. | $67.17 | 2020-2023 | Erleada |
| 180 Medical, INC. | $61.54 | 2021-2023 | Speedicath |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $61.41 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Acerus Pharmaceuticals Corporation | $39.26 | 2020-2022 | |
| Hollister Incorporated | $36.52 | 2023-2025 | Infyna Chic, Vapro, Vapro Plus Pocket |
| Merz Pharmaceuticals, LLC | $33.34 | 2021 | |
| Axonics, INC. | $31.13 | 2024 | Axonics |
| Pfizer INC. | $29.07 | 2019 | |
| Rochester Medical Corporation | $28.97 | 2019 | |
| Ferring Pharmaceuticals INC. | $23.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.97 | 2024 | |
| Neotract INC. | $19.08 | 2020 | |
| Merck Sharp & Dohme LLC | $18.63 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $18.14 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.